Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Window-of-Opportunity Trial of Nivolumab and BMS986205 in Patients With Squamous Cell Carcinoma of the Head and Neck (CA017-087)

NCT03854032 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03854032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03854032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Window-of-Opportunity Trial of Nivolumab and BMS986205 in Patients With Squamous Cell Carcinoma of the Head and Neck (CA017-087)
Lead sponsor
Thomas Jefferson University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 9, 2019
Completion date
December 31, 2025
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

larynx, lip, oral cavity squamous cell carcinoma, pharynx, squamous cell carcinoma